Literature DB >> 15071022

Identification of a protein biomarker unique to the pandemic O3:K6 clone of Vibrio parahaemolyticus.

Tracie L Williams1, Steven M Musser, Jessica L Nordstrom, Angelo DePaola, Steven R Monday.   

Abstract

The present method of characterizing Vibrio parahaemolyticus strains involves serotyping or detection methods based on assessment of the presence or absence of genes thought to be markers of an organism's pathogenicity. It is unclear whether these assays detect all pathogenic V. parahaemolyticus strains since a clear correlation between the presence of a particular gene and the organism's pathogenicity has not yet been observed. We have described a proteomics-based method to distinguish individual V. parahaemolyticus strains on the basis of their protein profiles and identified a specific protein that is characteristic of the pandemic O3:K6 strain and its clonal derivatives. In the pandemic clone of V. parahaemolyticus, a histone-like DNA-binding protein, HU-alpha, has a C-terminal amino acid sequence different from those of other strains of V. parahaemolyticus. Upon further study, it was discovered that the gene encoding this protein has a 16-kbp insert at the 3' terminus of the open reading frame for this protein. By using the protein sequence of the unique biomarker for the pandemic clone of V. parahaemolyticus, it was possible to rationally design specific PCR-based probes and assays that permit the rapid and precise identification of pandemic strains of V. parahaemolyticus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071022      PMCID: PMC387615          DOI: 10.1128/JCM.42.4.1657-1665.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

Review 1.  Characterization of intact microorganisms by MALDI mass spectrometry.

Authors:  C Fenselau; P A Demirev
Journal:  Mass Spectrom Rev       Date:  2001 Jul-Aug       Impact factor: 10.946

Review 2.  MALDI-TOF mass spectrometry of bacteria.

Authors:  J O Lay
Journal:  Mass Spectrom Rev       Date:  2001 Jul-Aug       Impact factor: 10.946

3.  Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae.

Authors:  Kozo Makino; Kenshiro Oshima; Ken Kurokawa; Katsushi Yokoyama; Takayuki Uda; Kenichi Tagomori; Yoshio Iijima; Masatomo Najima; Masayuki Nakano; Atsushi Yamashita; Yoshino Kubota; Shigenobu Kimura; Teruo Yasunaga; Takeshi Honda; Hideo Shinagawa; Masahira Hattori; Tetsuya Iida
Journal:  Lancet       Date:  2003-03-01       Impact factor: 79.321

4.  Automated postprocessing of electrospray LC/MS data for profiling protein expression in bacteria.

Authors:  Tracie L Williams; Peter Leopold; Steven Musser
Journal:  Anal Chem       Date:  2002-11-15       Impact factor: 6.986

5.  Genotyping of pandemic Vibrio parahaemolyticus O3:K6 still open to question.

Authors:  Ro Osawa; Atsushi Iguchi; Eiji Arakawa; Haruo Watanabe
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

6.  Emergence of a restricted bioserovar of Vibrio parahaemolyticus as the predominant cause of Vibrio-associated gastroenteritis on the West Coast of the United States and Mexico.

Authors:  S L Abbott; C Powers; C A Kaysner; Y Takeda; M Ishibashi; S W Joseph; J M Janda
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  Comparative phenotypic, molecular, and virulence characterization of Vibrio parahaemolyticus O3:K6 isolates.

Authors:  P S Marie Yeung; Micaela C Hayes; Angelo DePaola; Charles A Kaysner; Laura Kornstein; Kathryn J Boor
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

Review 8.  Diseases of humans (other than cholera) caused by vibrios.

Authors:  P A Blake; R E Weaver; D G Hollis
Journal:  Annu Rev Microbiol       Date:  1980       Impact factor: 15.500

9.  Mass spectrometric methods for generation of protein mass database used for bacterial identification.

Authors:  Zhengping Wang; Kevin Dunlop; S Randolph Long; Liang Li
Journal:  Anal Chem       Date:  2002-07-01       Impact factor: 6.986

10.  Genotypic analyses of Vibrio parahaemolyticus and development of a pandemic group-specific multiplex PCR assay.

Authors:  Masatoshi Okura; Ro Osawa; Atsushi Iguchi; Eiji Arakawa; Jun Terajima; Haruo Watanabe
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

View more
  16 in total

1.  Identification of a DNA methyltransferase gene carried on a pathogenicity island-like element (VPAI) in Vibrio parahaemolyticus and its prevalence among clinical and environmental isolates.

Authors:  Hui-zhen Wang; Minnie M L Wong; Desmond O'Toole; Mandy M H Mak; Rudolf S S Wu; Richard Y C Kong
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

2.  Identification of Vibrio parahaemolyticus pandemic group-specific DNA sequence by genomic subtraction.

Authors:  Masatoshi Okura; Ro Osawa; Eiji Arakawa; Jun Terajima; Haruo Watanabe
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Identifying new PCR targets for pathogenic bacteria using top-down LC/MS protein discovery.

Authors:  Tracie L Williams; Steven R Monday; Peter C H Feng; Steven M Musser
Journal:  J Biomol Tech       Date:  2005-06

Review 4.  Global dissemination of Vibrio parahaemolyticus serotype O3:K6 and its serovariants.

Authors:  G Balakrish Nair; Thandavarayan Ramamurthy; Sujit K Bhattacharya; Basabjit Dutta; Yoshifumi Takeda; David A Sack
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

5.  Liquid chromatography/mass spectrometry characterization of Escherichia coli and Shigella species.

Authors:  Robert A Everley; Tiffany M Mott; Shane A Wyatt; Denise M Toney; Timothy R Croley
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-15       Impact factor: 3.109

6.  The Vibrio parahaemolyticus ToxRS regulator is required for stress tolerance and colonization in a novel orogastric streptomycin-induced adult murine model.

Authors:  W Brian Whitaker; Michelle A Parent; Aoife Boyd; Gary P Richards; E Fidelma Boyd
Journal:  Infect Immun       Date:  2012-03-05       Impact factor: 3.441

7.  Virulence gene- and pandemic group-specific marker profiling of clinical Vibrio parahaemolyticus isolates.

Authors:  Carolyn E Meador; Michele M Parsons; Cheryl A Bopp; Peter Gerner-Smidt; John A Painter; Gary J Vora
Journal:  J Clin Microbiol       Date:  2007-02-14       Impact factor: 5.948

8.  Four genomic islands that mark post-1995 pandemic Vibrio parahaemolyticus isolates.

Authors:  Catherine C Hurley; AnneMarie Quirke; F Jerry Reen; E Fidelma Boyd
Journal:  BMC Genomics       Date:  2006-05-03       Impact factor: 3.969

9.  Genome plasticity of Vibrio parahaemolyticus: microevolution of the 'pandemic group'.

Authors:  Haihong Han; Hin-Chung Wong; Biao Kan; Zhaobiao Guo; Xiaotao Zeng; Shengjun Yin; Xiumei Liu; Ruifu Yang; Dongsheng Zhou
Journal:  BMC Genomics       Date:  2008-11-28       Impact factor: 3.969

Review 10.  Distribution and dynamics of epidemic and pandemic Vibrio parahaemolyticus virulence factors.

Authors:  Daniela Ceccarelli; Nur A Hasan; Anwar Huq; Rita R Colwell
Journal:  Front Cell Infect Microbiol       Date:  2013-12-11       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.